Sensus Healthcare (SRTS) Free Cash Flow (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sensus Healthcare | 47.41 Mn | 29.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.82% |
| Dec 31, 2025 | -203.23% |
| Sep 30, 2025 | -25.86% |
| Jun 30, 2025 | 215.13% |
| Mar 31, 2025 | -406.42% |
| Dec 31, 2024 | -114.66% |
| Sep 30, 2024 | -14.45% |
| Jun 30, 2024 | 150.20% |
| Mar 31, 2024 | -415.59% |
| Dec 31, 2023 | 519.03% |
| Sep 30, 2023 | -39.55% |
| Jun 30, 2023 | 111.53% |
| Mar 31, 2023 | 38.89% |
| Dec 31, 2022 | -376.36% |
| Sep 30, 2022 | 97.89% |
| Jun 30, 2022 | -39.07% |
| Mar 31, 2022 | 267.11% |
| Dec 31, 2021 | -245.44% |
| Sep 30, 2021 | -7.34% |
| Jun 30, 2021 | 212.89% |
| Mar 31, 2021 | -157.54% |
| Dec 31, 2020 | 83.11% |
| Sep 30, 2020 | -229.64% |
| Jun 30, 2020 | 608.70% |
| Mar 31, 2020 | -50.32% |
| Dec 31, 2019 | 131.05% |
| Sep 30, 2019 | -132.54% |
| Jun 30, 2019 | 183.57% |
| Mar 31, 2019 | -308.43% |
| Dec 31, 2018 | 30.95% |
| Sep 30, 2018 | -82.92% |
| Jun 30, 2018 | 63.31% |
| Mar 31, 2018 | -603.32% |
| Dec 31, 2017 | 179.87% |
| Sep 30, 2017 | -592.97% |
| Jun 30, 2017 | 95.53% |